PT  - JOURNAL ARTICLE
AU  - Zhang, Wenwen
AU  - Tong, Shuang
AU  - Hu, Bingyang
AU  - Wan, Tao
AU  - Tang, Haowen
AU  - Zhao, Feilong
AU  - Jiao, Tianyu
AU  - Li, Junfeng
AU  - Zhang, Ze
AU  - Cai, Jinping
AU  - Ye, Huiyi
AU  - Wang, Zhanbo
AU  - Chen, Shiqing
AU  - Wang, Yafei
AU  - Li, Xuerui
AU  - Wang, Fangzhou
AU  - Cao, Junning
AU  - Tian, Lantian
AU  - Zhao, Xiaochen
AU  - Chen, Mingyi
AU  - Wang, Hongguang
AU  - Cai, Shouwang
AU  - Hu, Minggen
AU  - Bai, Yuezong
AU  - Lu, Shichun
TI  - Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
AID  - 10.1136/jitc-2023-007366
DP  - 2023 Sep 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e007366
VI  - 11
IP  - 9
4099  - http://jitc.bmj.com/content/11/9/e007366.short
4100  - http://jitc.bmj.com/content/11/9/e007366.full
SO  - J Immunother Cancer2023 Sep 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.